NADIR PSA and time to NADIR PSA after radiotherapy +/- androgen deprivation as a predictor of prostate cancer outcome.

被引：0
|
作者：
Sancho Pardo, G.
GAmez de Segura, G.
Gich, I.
FarrA, N.
Membrive, I.
Trilla, J.
RosellA, A.
机构：
[1] Hosp Santa Creu & Santa Pau, Dept Radiotherapy & Radiat Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Santa Pau, Serv Clin Epidemiol & Publ Hlth, Barcelona, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1106
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [21] Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer
    Hamano, Itsuto
    Hatakeyama, Shingo
    Narita, Shintaro
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    WORLD JOURNAL OF UROLOGY, 2019, 37 (11) : 2365 - 2373
  • [22] PSA nadir and time to nadir as independent predictors of PSA failure-free survival in prostate carcinoma
    Chandra, A
    Levy, LB
    Kuban, DA
    RADIOLOGY, 2002, 225 : 320 - 321
  • [23] Can PSA nadir predict prostate cancer outcomes following radiotherapy?
    Danny Y Song
    Theodore L DeWeese
    Nature Clinical Practice Urology, 2006, 3 : 464 - 465
  • [24] The PSA nadir coal for radiotherapy of prostate cancer is ≤0.2 ng/ml
    Critz, FA
    Levinson, AK
    Williams, WH
    Holladay, DA
    Holladay, CT
    Griffin, VD
    JOURNAL OF UROLOGY, 1998, 159 (05): : 218 - 218
  • [25] The PSA nadir that indicates potential cure after radiotherapy for prostate cancer - Editorial comment
    Klein, EA
    Kupelian, PJ
    UROLOGY, 1997, 49 (03) : 326 - 326
  • [26] Can PSA nadir predict prostate cancer outcomes following radiotherapy?
    Song, Danny Y.
    DeWeese, Theodore L.
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (09): : 464 - 465
  • [27] Role of statins and PSA nadir after androgen-deprivation therapy in overall survival of patients with metastatic prostate cancer
    Siddiqui, Salma
    Durbin-Johnson, Blythe P.
    Yap, Stanley A.
    White, Ralph W. deVere
    Ghosh, Paramita M.
    CANCER RESEARCH, 2019, 79 (13)
  • [28] The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naive Prostate Cancer Patients
    Sasaki, Takeshi
    Sugimura, Yoshiki
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [29] Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer
    Kitagawa, Yasuhide
    Ueno, Satoru
    Izumi, Kouji
    Kadono, Yoshifumi
    Mizokami, Atsushi
    Hinotsu, Shiro
    Akaza, Hideyuki
    Namiki, Mikio
    WORLD JOURNAL OF UROLOGY, 2016, 34 (03) : 319 - 327
  • [30] Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer
    Yasuhide Kitagawa
    Satoru Ueno
    Kouji Izumi
    Yoshifumi Kadono
    Atsushi Mizokami
    Shiro Hinotsu
    Hideyuki Akaza
    Mikio Namiki
    World Journal of Urology, 2016, 34 : 319 - 327
12345